Inventprise

About:

Inventprise is a biotechnology company specializing in GMP vaccine product development.

Top Investors: Bill & Melinda Gates Foundation

Description:

Inventprise is a biotechnology company specializing in GMP vaccine product development. Its vaccine candidate is a 25-valent pneumococcal conjugate vaccine (PCV) funded by the Bill and Melinda Gates Foundation (>$100M) and aimed at large-scale supply to Low-Middle Income Countries. The company was founded in 2012 and is headquartered in Redmond, Washington.

Total Funding Amount:

$90M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Redmond, Washington, United States

Founded Date:

2012-01-01

Contact Email:

info(AT)inventprise.com

Founders:

Number of Employees:

51-100

Last Funding Date:

2021-11-10

IPO Status:

Private

Industries: